Development of paclitaxel-loaded liposomal nanocarrier stabilized by triglyceride incorporation. - Wikidata - awgldk - TriplyDB

Development of paclitaxel-loaded liposomal nanocarrier stabilized by triglyceride incorporation.

Development of paclitaxel-loaded liposomal nanocarrier stabilized by triglyceride incorporation.

http://www.wikidata.org/entity/Q37248679

about

Distinct solubility and cytotoxicity regimes of paclitaxel-loaded cationic liposomes at low and high drug content revealed by kinetic phase behavior and cancer cell viability studies.2-Hydroxyoleic acid-inserted liposomes as a multifunctional carrier of anticancer drugs.

P2860

Q45932069-EAD5F20B-C569-4748-8CBC-0F3244214BC7 Q50065561-A57F1783-3938-4E1A-8F87-42AC92730F0A

P2860

Development of paclitaxel-loaded liposomal nanocarrier stabilized by triglyceride incorporation.

http://www.wikidata.org/entity/Q37248679

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 06 September 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Development of paclitaxel-load ...... by triglyceride incorporation.

@en

Development of paclitaxel-load ...... by triglyceride incorporation.

@nl

type

label

Development of paclitaxel-load ...... by triglyceride incorporation.

@en

Development of paclitaxel-load ...... by triglyceride incorporation.

@nl

prefLabel

Development of paclitaxel-load ...... by triglyceride incorporation.

@en

Development of paclitaxel-load ...... by triglyceride incorporation.

@nl

P1433

Q37248679-04037E03-2109-4BEA-9948-117E8532B564

P1476

Q37248679-1F73541A-F2F9-4B61-8E3C-60D99947FC9F

P2093

Q37248679-0A86B81E-9434-4482-83EF-3F8BF5AA3154

Q37248679-3D697A1C-DC73-4C78-8681-DF6376B8E396

Q37248679-43325324-A547-449A-9F99-A68389028C8C

Q37248679-B59EBA8A-47B3-4D99-9E64-59077493A290

Q37248679-C182DCCF-BCC7-40B0-9311-844E866E3E4C

Q37248679-FEA187FC-1CA5-4B02-8B5B-9B419B8E2E24

P2860

Q37248679-0299F969-52A0-4262-9B29-A49FC724854A

Q37248679-089736D8-5271-484F-9A11-46D78D2CBAC4

Q37248679-08EC416B-65FF-4D40-9F47-F95C70296308

Q37248679-12DF3A9E-2BB4-4454-A087-B407930D4C76

Q37248679-1718DDC1-5491-44AD-8039-0714B19720CF

Q37248679-278F2647-A179-4E12-8598-AE139A474836

Q37248679-29F8B54A-A07C-4C43-9DD1-8E7A41A2B831

Q37248679-2C7E7BCA-B7C6-4873-AB1D-AFE0F1669661

Q37248679-39D01682-7CF2-44D8-98CC-3F5ED0C28512

Q37248679-45BC4D1F-3AF6-443D-BA9D-008C0ED6F7D0

P304

Q37248679-C91D71F1-1735-4FE7-B59F-BF9EE8ECC1C0

P31

Q37248679-C08FE0F0-C241-491B-BF10-E7AD76C91C99

P356

Q37248679-C09CEAAD-04BF-4881-BC0F-9505F8064AA0

P407

Q37248679-6FBB1733-5676-4BE5-AF0C-DF19C981ADC0

P478

Q37248679-5BF5ED74-FA44-44CA-9A3B-6CC26763D86D

P577

Q37248679-B4785820-D542-4BE0-ACBD-F2F54CC55022

P698

Q37248679-5BF7319E-955B-45B5-91E7-83C585E7E984

P921

Q37248679-68DC1CE0-D8DE-4CBF-8B76-34498BBDD533

Q37248679-D3659891-391D-49C7-94E0-818EA9F6B625

P932

Q37248679-41F0EB09-F481-4748-AAD7-EF05006237B2

P356

P1433

International Journal of Nanomedicine

P1476

Development of paclitaxel-load ...... by triglyceride incorporation.

@en

P2093

Jong Oh Kim

http://www.w3.org/2001/XMLSchema#string

Ju Yeon Choi

http://www.w3.org/2001/XMLSchema#string

Mi-Kyung Lee

http://www.w3.org/2001/XMLSchema#string

So Hee Kim

http://www.w3.org/2001/XMLSchema#string

Soo-Jeong Lim

http://www.w3.org/2001/XMLSchema#string

Soon-Seok Hong

http://www.w3.org/2001/XMLSchema#string

P2860

Fat emulsions for parenteral nutrition. I: Evaluation of microscopic and laser light scattering methods for the determination of the physical stability.

Preparation and in vitro evaluation of anti-VCAM-1-Fab'-conjugated liposomes for the targeted delivery of the poorly water-soluble drug celecoxib.

Nanoparticle albumin-bound paclitaxel: a novel Cremphor-EL-free formulation of paclitaxel.

A liposomal formulation able to incorporate a high content of Paclitaxel and exert promising anticancer effect

Effect of liposome characteristics and dose on the pharmacokinetics of liposomes coated with poly(amino acid)s.

Paclitaxel-conjugated PAMAM dendrimers adversely affect microtubule structure through two independent modes of action.

Hydrotropic polymer micelles containing acrylic acid moieties for oral delivery of paclitaxel.

Lyophilization of a triply unsaturated phospholipid: effects of trace metal contaminants

Second generation liposomal cancer therapeutics: transition from laboratory to clinic.

Liprosomes loading paclitaxel for brain-targeting delivery by intravenous administration: in vitro characterization and in vivo evaluation.

P304

4465-4477

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/IJN.S113723

http://www.w3.org/2001/XMLSchema#string

P407

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27660440

http://www.w3.org/2001/XMLSchema#string

P921

P932

5019274

http://www.w3.org/2001/XMLSchema#string